Intra-arterial therapies for liver cancer: assessing tumor response.

about

MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism.Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.

P2860

Q50067689-6B4FBA20-8B28-4962-950F-A9FBE0032E70 Q55364224-E3E7C677-AFD6-4C02-9E56-8745AD4F3430

P2860

Intra-arterial therapies for liver cancer: assessing tumor response.

Item

http://www.wikidata.org/entity/Q39041266

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intra-arterial therapies for liver cancer: assessing tumor response.

@en

Intra-arterial therapies for liver cancer: assessing tumor response.

@nl

type

Item

label

Intra-arterial therapies for liver cancer: assessing tumor response.

@en

Intra-arterial therapies for liver cancer: assessing tumor response.

@nl

prefLabel

Intra-arterial therapies for liver cancer: assessing tumor response.

@en

Intra-arterial therapies for liver cancer: assessing tumor response.

@nl

P1476

Intra-arterial therapies for liver cancer: assessing tumor response.

@en

P2093

Brian S Letzen

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Geschwind

http://www.w3.org/2001/XMLSchema#string

Johanna M M van Breugel

http://www.w3.org/2001/XMLSchema#string

Julius Chapiro

http://www.w3.org/2001/XMLSchema#string

Yasmin W Stroehl

http://www.w3.org/2001/XMLSchema#string

P2860

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

The assessment of tumor response by measuring the single largest lesion per organ in metastatic tumors: a pooled analysis of previously reported data.

Validation of novel imaging methodologies for use as cancer clinical trial end-points

Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.

P304

119-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2017.1273775

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27983883

http://www.w3.org/2001/XMLSchema#string

Intra-arterial therapies for liver cancer: assessing tumor response.

about

P2860

P2860

Intra-arterial therapies for liver cancer: assessing tumor response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698